Director, Patient Experience Marketing

USA (Remote)

$215K/yr – $235K/yrDirector/Executive10+ years expFull time

Posted 6 days ago

Job Summary

Own and drive the NMIBC patient strategy across the brand, leading launch readiness, education, segmentation and advocacy partnerships to shape patient experience and access.

  • Owns the patient strategy, messaging, and journey development
  • Leads launch readiness, digital engagement, and education initiatives
  • Partners with Medical Affairs, Market Access, and patient organizations to inform strategy

Job Description

Responsibilities

  • Develop and own the integrated patient and caregiver strategy for cretostimogene.
  • Translate the overall brand strategy into a clear patient strategy, including objectives, strategic imperatives, priorities and measures of success.
  • Lead patient launch readiness across disease education, branded communications, digital engagement, patient support and treatment-experience initiatives.
  • Develop the patient value proposition, positioning, messaging and creative strategy in partnership with the broader brand team.
  • Develop and continually refine a comprehensive NMIBC patient journey from diagnosis through treatment and follow-up.
  • Identify the critical behavioral, emotional and practical barriers affecting treatment decisions.
  • Understand how patients and caregivers perceive disease severity, recurrence, progression risk and available treatment alternatives.
  • Build a deep understanding of patients, caregivers and their treatment decision-making process through primary and secondary research.
  • Lead development of actionable patient segmentation and patient personas.
  • Identify differences in needs, motivations and behaviors across relevant NMIBC patient populations.

Requirements

  • Bachelor’s degree in marketing, business administration or a related field or equivalent years of experience required. MBA or other graduate degree preferred.
  • Ten (10+) years marketing experience with 7+ in patient and consumer marketing.
  • Experience working in pharmaceutical brand marketing.
  • Oncology experience strongly preferred; urology, bladder cancer or other physician-administered oncology experience highly desirable.
  • Demonstrated experience preparing for and/or executing a pharmaceutical product launch.
  • Experience developing patient strategy, segmentation, positioning, messaging and omnichannel programs.
  • Strong understanding of the oncology patient journey and treatment decision-making process.
  • Experience partnering with Patient Services, Market Access and patient advocacy organizations.
  • Understanding of reimbursement and access considerations affecting patients receiving physician-administered therapies.
  • Experience leading agencies and managing significant marketing budgets.

Benefits

  • Well-Being Benefits eligibility begins the 1st of the month after hire. While a majority of these benefits are for our US-based workforce, we continue to assess comparable levels of benefits for our international team members that are aligned with country-specific regulations and their national programs offered.
  • FULLY REMOTE WORK ENVIRONMENT
  • REST AND RECHARGE BENEFITS - Unlimited Flexible Time Off
  • HOLIDAYS - In 2026 we will observe 14 holidays
  • RETIREMENT - 401K with 100% company Safe Harbor match up to 4% of base salary
  • HEALTH (MEDICAL, DENTAL, VISION) - PPO & HDHP - Cigna/Principal
  • HEALTH SPENDING ACCOUNTS - HSA (with Annual Company Contribution), FSA, FSA-DC
  • ILLNESS & DISABILITY PROTECTION - Company Paid LTD Coverage + Voluntary Plans
  • LIFE INSURANCE - Company Paid 2 x base salary + Voluntary Plans
  • ADDITIONAL EXCLUSIVE BENEFITS - Voluntary Legal, Pet, Plus More
CG Oncology Inc logo

CG Oncology Inc

1.5 Glassdoor

CG Oncology, Inc. (Nasdaq: CGON), is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative oncolytic immunotherapies to live with dignity and have an enhanced quality of life.Our lead candidate, cretostimogene grenadenorepvec, is an intravesically delivered oncolytic immunotherapy agent in a Phase 3 trial for the treatment of BCG-unresponsive non-muscle invasive bladder cancer. Cretostimogene grenadenorepvec is also in a Phase 2 study in combination with KEYTRUDA® (pembrolizumab) in the same indication. Other types of bladder cancer are being evaluated with cretostimogene grenadenorepvec in combination with OPDIVO® (nivolumab).

Founded in 2010
Irvine, California, USA
177 employees (9 in marketing)
0% recommend to a friend

Salaries

Posted range

$215K/yr – $235K/yr

Taken straight from the job posting.

See all CG Oncology Inc salaries

Marketing Team

Marketing Team Size
9 (5% of company)
Median Tenure
2.2 years
Marketing Roles Posted (Last 30 Days)
3

Funding

Total Funding
$555.6M
Last Raise
$238M
Post IPO Equity, 1 years ago

Funding History

  • Dec 2024
    Post IPO Equity • $238M
  • Aug 2023
    Series F • $105M
  • Nov 2022
    Series E • $120M

Traffic Signals

Monthly Visitors
9.8K
Monthly Google Ads Budget
$3.7K
Traffic Source Mix
Search
39.9%
Direct
43.5%
Referral
5.6%
Social
9.8%
Paid
1.2%

Headcount Trend

Current headcount: ~176
CG Oncology Inc logo

Director, Patient Experience Marketing

CG Oncology Inc · USA · Remote